Evidence map›Paper›PMID 34684027›Full record

ArticlePharmaceutics2021

A Novel Method for Predicting the Human Inherent Clearance and Its Application in the Study of the Pharmacokinetics and Drug-Drug Interaction between Azidothymidine and Fluconazole Mediated by UGT Enzyme.

Yawen Yuan, Jun Zhang, Boyu Fang, Xiaoqiang Xiang, Guo Ma, Shunguo Zhang, Bin Zhu, Weimin Cai

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. A clinical drug-drug interaction assessment using physiologically based pharmacokinetic modeling: a case study with chloroquine and colchicine.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yawen YuanDepartment of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai 201203, China.
Jun ZhangDepartment of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai 201203, China.
Boyu FangDepartment of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai 201203, China.
Xiaoqiang XiangDepartment of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai 201203, China.ORCID 0000-0002-8683-2603
Guo MaDepartment of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai 201203, China.
Shunguo ZhangShanghai Children's Medical Center, Pharmacy Department, Shanghai 20127, China.
Bin ZhuShanghai BaiO Technology Company, Shanghai 200233, China.
Weimin CaiDepartment of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai 201203, China.
Fudan University · CNBaidu (China) · CNShanghai Children's Medical Center · CN

Funding

National Natural Science Foundation of China 81673501
6 · The paper itself

Abstract

In order to improve the benefit-risk ratio of pharmacokinetic (PK) research in the early development of new drugs, in silico and in vitro methods were constructed and improved. Models of intrinsic clearance rate (CL

Indexed as

azidothymidineclearancedrug interactionmetabolic systemPBPK modelQSAR

Identifiers

PMID34684027
PMCPMC8538957
OpenAlexW3206313995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.